STAT
STAT, citing the AP, notes the peptides involved aren't FDA approved as safe or effective and most of their data comes from animal studies.
Recap by typeshit. Full story at STAT.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
A Maryland man has taken Novo Nordisk's drug to court, saying in his filing that Ozempic led to his loss of sight. Details are at the link.
A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018, while a Tulane surgeon says Louisiana insurance favors surgery.
Loading…